Public Release: 

Announcing PCR London Valves 2018: The world's largest meeting for the Heart Valve Team


The ninth edition of the annual Heart Team Course will take place from Sept. 9-11, 2018, at the ExCeL London. The unique exchange platform aims to keep participants aligned with the constant evolution of patient care in the fast-growing field of transcatheter therapies for valvular heart disease.

A steady rise in the number of participants

Interventional cardiologists, surgeons, imaging specialists, anaesthesiologists, intensive care physicians, nurses and allied professionals will gather from across the globe for 3 days of learning and sharing. The level of attendance is in progress since the creation of the Course in 2010, and the number of participants has doubled over the past six years. The last edition counted over 2,500 from 70 different countries.

A focus on imaging throughout, including new structural imaging workshops

A dedicated Imaging Day will again mark the beginning of the Course, on Sunday 9 September. It will include highly educational and hands-on content that covers imaging for aortic, mitral and tricuspid valve interventions, as well as tutorials on current capabilities and forthcoming innovations in the field. The focus on imaging will continue throughout the Course, in particular as PCR London Valves is to act as forerunner as it hosts some innovative new structural imaging workshops, prior to their implementation in other PCR initiatives. They will deal with the appreciation of 3D cardiac anatomy and the correlation between imaging modalities, by demonstrating the use of multi-slice computed tomography as a central tool to better understand fluoroscope and echocardiographic imaging. These 4 limited-capacity 90' modular workshops will be held in the new Imaging Learning Centre.

A Course made By and For the community at large

One of the most ambitious programmes to date includes numerous interactive sessions built using submissions reviewed and selected amongst hundreds received following the Call for Clinical Cases, Abstracts, Innovations and Late-Breaking Trials. Sessions dedicated to Nurses and Allied Professionals will touch on the realities of caring for the elderly patient and also address the assessment of patients for early discharge following TAVI. All participants will be invited to take an active part, sharing and learning from the experience of their peers.

Spotlights set to gather keen interest

Among the keynote lectures, David J. Cohen of Saint Luke's Mid America Heart Institute in Kansas City will deliver "Percutaneous valve intervention in a global market - a big deal". He will tackle the important socio-economic implications of rapidly expanding programmes of transcatheter valve interventions. 2018 marks the 15th anniversary of the very first mitral edge-to-edge procedures, and the spotlight on emerging European MITRA-FRANCE RCT data concerning mitral edge-to-edge repair will highlight the implications of the findings for guidelines and everyday practice.

LIVE demonstrations remain a key feature of the Course

A total of 8 sessions in the Main Arena will include LIVE demonstrations from 3 centres: Swiss Cardiovascular Centre, Bern University Hospital, Switzerland; Centro Alte Specialità e Trapianti, University of Catania, Italy; and St Thomas' Hospital, London, United Kingdom. They will showcase both routine and challenging aortic, mitral and tricuspid cases, providing participants will valuable and practical takeaways for their own cathlabs.

Renewed two-level curriculum for all Heart Valve Team members

The Course Directors have again chosen to identify Learning sessions in the Programme as being either 'Essential' or 'Applied'. The former provide opportunities for those relatively new to the field and the latter focus on more challenging cases and procedures.

The Course positions itself as the place to be for innovation

A dedicated PCR Innovators Day London, taking place on Sunday 9 September, will connect the key stakeholders in innovation, and is mainly dedicated to showcasing novel, promising and disruptive technologies. It is structured for all members of the percutaneous valve community: clinicians, innovators, MedTech executives, investors, trialists and regulators.

Innovation will play a foremost role throughout the whole of PCR London Valves, including the presentation of new devices, research and late-breaking trials*, as well as an enlarged 810 m² industry-led Training Village with many practical workshops focused on innovative technologies. These include those of the HeartLab, an educational concept that provides hands-on simulator and case-based training for mastering the techniques of transeptal puncture; it is developed by Professor Francesco Maisano of the Zurich Mitral Valve Meeting, as the first step to a future collaboration with PCR, announced for 2019.

Special digital scientific coverage before, during and after the Course

This year the active Young Practitioners Group will be ensuring maximum digital coverage of PCR London Valves. Their initiatives include cardio polls on hot topics and the broadcasting of short take-home message videos after sessions. The group encourages participants and non-participants alike to access the PCR App and social media to keep apace with the Course and share their own feedback, using the hashtag #PCRLV and @PCRonline.

*Late-Breaking Trials to be presented at PCR London Valves:

  • The multicentre European FAST-TAVI trial: feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation (by M. Barbanti)
  • Direct left ventricular rapid pacing via the valve delivery guidewire in TAVI: a randomised study (by B. Faurie)
  • OCEAN-TAVI registry: Mid-term result of transcatheter aortic valve implantation in Japan (by K. Hayashida)
  • Early commercial experience using the Portico transcatheter aortic valve: 30-day outcomes in 973 patients enrolled in the Portico I study - cohort A (by S. Worthley)
  • TAVR for failed surgical aortic bioprostheses using a self-expanding device: one-year outcomes from the prospective VIVA post-market study (by D. Tchétché)
  • Transfemoral implantation of the ACURATE neo prosthesis using a low profile expandable introducer system: a multicentre analysis (by W.K. Kim)
  • An early feasibility study to assess safety and effectiveness of a novel transfemoral TAVR system in the treatment of patients with symptomatic severe aortic stenosis (by H. Treede)
  • One-year outcomes of patients with severe aortic stenosis and an STS-PROM of less than three percent in the SURTAVI trial (by P.W. Serruys)

Address and dates to remember:

ExCeL London - Royal Victoria Dock, 1 Western Gateway - West entrance - Hall S1-S2
> PCR London Valves - 9-11 September 2018
> PCR Imaging Day - Sunday 9 September 2018
> PCR Innovators Day - Sunday 9 September 2018


For any press-related enquiries, please contact PCR London Valves Press Coordinator, Isabelle Uzielli:

Register and attend PCR London Valves 2018 as a journalist

Press registration for PCR London Valves 2018 is open to accredited journalists, free of charge. Journalists must hold a valid press card and/or provide a letter of assignment from a recognised publication. To register:

PCR London Valves press releases

Press releases can be found at

PCR London Valves abstracts

Abstracts are available online at



What is PCR London Valves?

Created to keep abreast with the constant evolution of transcatheter therapies for valvular heart disease, PCR London Valves is the world's largest educational meeting dedicated to the field. It is an official course of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in recognition of the quality and relevance of its programmes in advancing percutaneous valve interventions. It is also one of the approved continuing medical education (CME) meetings under the new MedTech Code of Ethical Business Practice.

The annual Course provides a unique 3-day forum for education and interaction between interventional cardiologists, surgeons, imaging specialists, anesthesiologists, intensive care physicians, nurses and allied professionals. It has become an essential rendez-vous for all members of the Heart Team looking to stay on the cutting edge of clinical knowledge in this fast-growing field.

About PCR

The mission of PCR is to serve the needs of each individual patient by helping the cardiovascular community to share knowledge, experience and practice. PCR offers a large range of many other educational meetings and resources for the continuing education of the interventional cardiovascular community. These include major annual Courses across the globe, E-Learning with high- profile PCR Webinars, Courses specifically dedicated to valvular heart disease, tailor-made PCR Seminars on specific topics, online resources and medical publications such as EuroIntervention, the official journal of the EAPCI.

For more information, please visit: and follow us on Twitter using the hashtag #PCRLV

Gateways to all PCR activities are available on

For further information, please contact: Célia Vilà:

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.